Screener
Tandem Diabetes Care TNDM Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001438133-26-000125
| Assets | June 30, 2026 / (Unaudited) | December 31, 2025 / (Note 1) |
|---|---|---|
| Total liabilities | 1,023,814 | 725,942 |
| Commitments and contingencies (Note 14) | — | — |
| Stockholders’ equity: | ||
| Common stock, $0.001 par value; 200,000 shares authorized, 69,540 and 68,291 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 70 | 68 |
| Additional paid-in capital | 1,418,011 | 1,402,044 |
| Accumulated other comprehensive income | 6,403 | 5,593 |
| Accumulated deficit | (1,294,096) | (1,252,535) |
| Total stockholders’ equity | 130,388 | 155,170 |
Item 1. Financial Statements.
FAQ
- What is Tandem Diabetes Care's common stock?
- Tandem Diabetes Care (TNDM) reported common stock of 200M in Q2 2026.
- How has Tandem Diabetes Care's common stock changed year-over-year?
- Tandem Diabetes Care's common stock decreased by 0.0% year-over-year, from 200M to 200M.
- What is the long-term trend for Tandem Diabetes Care's common stock?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's common stock has grown at a 403.2% compound annual growth rate (CAGR), from 62K to 200M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Tandem Diabetes Care's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude